New gene-editing platform gives doctors control over cell therapies
An Australian clinician-led research team has developed a gene-editing platform that could give doctors more control over cell therapies, making them more practical for patients with complex immune conditions.
Read original article on The Medical News →Related news
-
Wearable pressure sensor uses cold-spray adhesion method for enhanced health monitoring
United Kingdom
-
Childhood measles vaccination rates fall worldwide post-COVID-19
United Kingdom
-
Experimental treatment selectively reduces harmful protein in lab models of rare inherited brain disorder
United Kingdom
-
Existing cancer drug reduces blood vessel malformations in the brain
United Kingdom
-
Tuberculosis vaccine's link to reduced dementia risk gains mechanistic support
United Kingdom
-
'Digital twins' of immune system in pregnancy identify drugs to prevent early labor
United Kingdom
-
Nearly half of on-duty firefighter deaths are heart-related
United Kingdom
-
Modifiable psychosocial factors linked to depression among US cancer survivors
United Kingdom